🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine if a new drug, RO4929097, can wor...
Status
Terminated
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2010-09
Trial ID
NCT01198535
This research study is evaluating the safety and efficacy of a combination ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2020-07-20
Trial ID
NCT04290546
Treatments Being Tested
This is a multicenter, single-arm, phase II clinical study evaluating the e...
Status
Enrolling By Invitation
Location
The First People's Hospital of Foshan
Start Date
2026-04-20
Trial ID
NCT07618624
This study is a single-arm, multi-center, prospective clinical study aimed ...
Status
Not Yet Recruiting
Location
The Second Affiliated Hospital of Soochow University
Start Date
2025-12-27
Trial ID
NCT07327411
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as paclitaxel albumin-stabilize...
Status
Completed
Location
Baylor Research Institute
Start Date
2009-03-01
Trial ID
NCT00851877
Treatments Being Tested
TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion cl...
Status
Recruiting
Location
Arizona Oncology Associates
Start Date
2020-07-14
Trial ID
NCT04485013
This is a clinical research study taking place in Germany. Patients with co...
Status
Recruiting
Location
Charité - Universitaetsmedizin Berlin
Start Date
2025-04-10
Trial ID
NCT06922383
Treatments Being Tested
This study will assess the safety and efficacy of LGX818 when combined with...
Status
Completed
Location
Keck Hospital of USC
Start Date
2012-11-23
Trial ID
NCT01719380
This is a prospective, multicenter, randomized controlled, phase II study. ...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-06-01
Trial ID
NCT07621497
This is a three-part study of NUC-3373 administered by intravenous (IV) inf...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2018-10-05
Trial ID
NCT03428958